VHIAX
Price
$44.17
Change
+$0.01 (+0.02%)
Updated
Dec 3 closing price
Net Assets
23.69B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

VHIAX vs VIGRX

Header iconVHIAX vs VIGRX Comparison
Open Charts VHIAX vs VIGRXBanner chart's image
JPMorgan Growth Advantage A
Price$44.17
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets23.69B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
VHIAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
VHIAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VHIAX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. VHIAX (23.7B). VIGRX pays higher dividends than VHIAX: VIGRX (0.30) vs VHIAX (0.00). VHIAX was incepted earlier than VIGRX: VHIAX (26 years) vs VIGRX (33 years). VHIAX (1.08) is less costly to investors than VIGRX (0.17). VHIAX is a more actively managed with annual turnover of: 36.00 vs. VIGRX (11.00). VHIAX has a lower initial minimum investment than VIGRX: VHIAX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. VHIAX (7.81). VIGRX return over 5 years is better than : 99.11 vs. VHIAX (37.39).
VHIAXVIGRXVHIAX / VIGRX
Total Expense Ratio0.990.17582%
Annual Report Gross Expense Ratio1.080.17635%
Fund Existence26 years33 years-
Gain YTD16.94519.76486%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B357B7%
Annual Yield % from dividends0.000.30-
Returns for 1 year7.8118.4942%
Returns for 3 years84.43110.8276%
Returns for 5 years37.3999.1138%
Returns for 10 years178.32349.1351%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT